Product Information
XACIATO 2% VAGINAL GEL is a brand product labeled by Organon LLC, priced at $18.8686 per GM under NDC 78206018901. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Dec 7, 2021.
The High Outlier badge above means this manufacturer's average price in the clindamycin phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/5g
Manufacturer
Organon LLCNDC
78206018901
Classification
Brand
Dosage Form
GEL
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA215650FDA Approved
12/7/2021
On Market Since
10/13/2023
Pharmacological Classes
Price Statistics
The NADAC for XACIATO 2% VAGINAL GEL has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.8686 per GM |
|---|---|
| All-time high | $18.9250 (Sep 16, 2026) |
| All-time low | $17.9768 (Mar 19, 2025) |
| 52-week high | $18.9250 |
| 52-week low | $18.0000 |
| Median price | $18.0148 |
| Average price | $18.3013 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XACIATO 2% VAGINAL GEL?
The current National Average Drug Acquisition Cost (NADAC) for XACIATO 2% VAGINAL GEL, manufactured by Organon LLC, is $18.8686 per GM (NDC 78206018901), effective Sep 30, 2026.
How has the price of XACIATO 2% VAGINAL GEL changed over time?
Over the history we have for it, the NADAC for XACIATO 2% VAGINAL GEL has risen 4.2%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for XACIATO 2% VAGINAL GEL?
Since Jul 17, 2024, the NADAC for XACIATO 2% VAGINAL GEL has ranged from a low of $17.9768 (Mar 19, 2025) to a high of $18.9250 (Sep 16, 2026), with a median of $18.0148 per GM.
Are there cheaper alternatives to XACIATO 2% VAGINAL GEL?
No other NADAC-published product currently shares the active ingredient and strength of XACIATO 2% VAGINAL GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XACIATO 2% VAGINAL GEL?
XACIATO 2% VAGINAL GEL (NDC 78206018901) is labeled by Organon LLC, and CMS classifies it as a brand product.